fbpx

Scroll down for references for this edition

PASSWORD:  Diabetes Management Journal is a medical journal exclusively for healthcare professionals. Apply for access here:

DMJ Access Application
Image

Diabetes Management Journal August 2018 References

NEWS & VIEWS REFERENCES

  1. Diabetes Australia. Peak health groups welcome government funding for new national diabetes eye screening program to prevent blindness. News, July 2018, available at https://www.diabetesaustralia.com.au/news/15522?type=articles
  2. Therapeutic Goods Administration. Safety advisory - diabetic ketoacidosis and surgical procedures. Alerts, 18 July 2018, available at https://www.tga.gov.au/alert/sodium-glucose-co-transporter-2-inhibitors
  3. Abdelhamid A, et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews, July 2018, available at http://cochranelibrary-wiley.com/doi/10.1002/14651858.CD003177.pub3/full
  4. Beran, D et al. Availability and affordability of essential medicines: Implications for global diabetes treatment Curr Diab Rep (Aug 2018) 18: 48.
  5. http://www.sciencemag.org/news/2018/05/could-deep-brain-stimulation-help-zap-diabetes, Science Translational Medicine 23 May 2018: Vol. 10, Issue 442, eaar3752 DOI: 10.1126/scitranslmed.aar3752


FEATURE REFERENCES

p10-14 How to Commence Insulin:

  1. Gunton JE, Cheung NW, Davis TM, Zoungas S, Colagiuri S. A new blood glucose management algorithm for type 2 diabetes: a position statement of the Australian Diabetes Society. Med J Aust. 2014;201(11):650-653.
  2. The Royal Australian College of General Practitioners and Australian Diabetes Society joint clinical position statement. Emergency management of hyperglycaemia in primary care. Australia; 2018. Available from: https://diabetessociety.com.au/documents/Emergencymanagementofhyperglycaemiainprimarycare.pdf
  3. Cheung NW, Conn JJ, d'Emden MC, Gunton JE, Jenkins AJ, Ross GP, et al. Position statement of the Australian Diabetes Society: individualisation of glycated haemoglobin targets for adults with diabetes mellitus. Med J Aust. 2009;191(6):339-344.
  4. The Pharmaceutical Benefits Scheme. PBS Schedule search for "insulin". Australian Government Department of Health. July 2018. Available from: http://www.pbs.gov.au/pbs/search?term=insulin.
  5. Tamez-Pérez HE, Quintanilla-Flores DL, Rodríguez-Gutiérrez R, González-González JG, Tamez-Peña AL. Steroid hyperglycemia: Prevalence, early detection and therapeutic recommendations: A narrative review. World J Diabetes. 2015;6(8):1073-1081.
  6. Frid AH, Kreugel G, Grassi G, Halimi S, Hicks D, Hirsch LJ, et al. New Insulin Delivery Recommendations. Mayo Clinic Proceedings. 2016;91(9):1231-1255.
  7. The Royal Australian College of General Practitioners. General practice management of type 2 diabetes: 2016–18. East Melbourne, Vic: RACGP, 2016. Available from: https://www.racgp.org.au/download/Documents/Guidelines/Diabetes/2015diabetesmanagement.pdf
  8. American Diabetes Association. Approaches to glycemic treatment. Sec. 7. In Standards of Medical Care in Diabetes—2016. Diabetes Care 2016;39(Suppl. 1):S52–S59.
  9. Abrahamson MJ, Peters A. Intensification of insulin therapy in patients with type 2 diabetes mellitus: An algorithm for basal-bolus therapy. Ann Med. 2012;44(8):836-846.
  10. Therapeutic good administration. Prescription medicines and biologicals: TGA annual summary 2017. Australian Government, Department of Health. Updated 26 March 2018. Available from: https://www.tga.gov.au/prescription-medicines-and-biologicals-tga-annual-summary-2017.
  11. Boehringer Ingelheim Pty Limited. Jardiance: empaliflozin film-coated tablets. Australian product information. 29 June 2018. Available from: https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2014-PI-01783-1&d=2018071216114622483.
  12. Thomas MC, Zimmet P, Shaw JE. Identification of obesity in patients with type 2 diabetes from Australian primary care: the NEFRON-5 study. Diabetes Care. 2006;29(12):2723-2725.
  13. Australian Health Ministers’ Advisory Council 2017. Diabetes in Australia: Focus on the future. Australian Government: Canberra. Available from: https://www.health.gov.au/internet/main/publishing.nsf/content/3AF935DA210DA043CA257EFB000D0C03/$File/FINAL%20-%20Jan%202018-%20PDF%20%20-%20Implementation%20Plan%20-%20Diabetes%20Australia%20Focus.pdf.


P17-19 Hypoglycaemia Management in General Practice:

  1. Austroads, National Transport Commission. Austroads - Assessing Fitness to Drive 2016 (as Amended up to August 2017).; 2016. https://www.onlinepublications.austroads.com.au/items/AP-G56-17. Accessed August 5, 2018.
  2. Diabetes Australia. Hypoglycaemia. https://www.diabetesaustralia.com.au/hypoglycaemia. Accessed July 1, 2018.
  3. Cryer PE. Hypoglycemia. In: Loriaux L, ed. Endocrine Emergencies: Recognition and Treatment. Totowa, NJ: Humana Press; 2014. doi:10.1007/978-1-62703-697-9.
  4. Sam AH, Meeran K. Lecture Notes. Endocrinology and Diabetes. Wiley-Blackwell; 2009. https://search.library.uq.edu.au/primo-explore/fulldisplay?docid=61UQ_ALMA2181162140003131&context=L&vid=61UQ&lang=en_US&search_scope=61UQ_All&adaptor=Local Search Engine&tab=61uq_all&query=any,contains,lecture notes endocrinology and diabetes , sam amir h. Accessed July 5, 2018.
  5. International Hypoglycaemia Study Group. Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2016. doi:10.2337/dc16-2215.
  6. Shaw J (Ed), Baker IDI Heart & Diabetes Institute, Diabetes Australia, Juvenile Diabetes Research Foundation. Diabetes: The Silent Pandemic and Its Impact on Australia.; 2012. https://static.diabetesaustralia.com.au/s/fileassets/diabetes-australia/e7282521-472b-4313-b18e-be84c3d5d907.pdf. Accessed July 9, 2018.
  7. Edridge CL, Dunkley AJ, Bodicoat DH, et al. Prevalence and Incidence of Hypoglycaemia in 532,542 People with Type 2 Diabetes on Oral Therapies and Insulin: A Systematic Review and Meta-Analysis of Population Based Studies. PLoS One. 2015;10(6):e0126427. doi:10.1371/journal.pone.0126427.
  8. Brisbane North Primary Health Network. Brisbane North HealthPathways: Hypoglycaemia. https://brisbanenorth.healthpathwayscommunity.org/index.htm. Published 2018.
  9. Australian Prescriber. Australian Prescriber Doctor’s Bag App. 2018.
  10. The Royal Children’s Hospital Melbourne. Clinical Practice Guidelines : Hypoglycaemia. https://www.rch.org.au/clinicalguide/guideline_index/hypoglycaemia_guideline/. Published 2016. Accessed August 5, 2018.
  11. Queensland Health. Queensland Health Protocol: Hypoglycaemia Management in Diabetes v3.00. 2013.


p20-22 Fit for it: Exercise and diabetes complications

  1. Australian Bureau of Statistics 2015. 4364.0.55.001 – National Health Survey: First Results, 2014-2015. Available at http://www.abs.gov.au/ausstats/abs@.nsf/PrimaryMainFeatures/4364.0.55.001?OpenDocument Accessed July 2018.
  2. McCarthy MM, Funk M & Grey M. Cardiovascular health in adults with type 1 diabetes. Prev Med 2016;9:138-143.
  3. Quirk H, Black H, Tennyson R, Randell TL & Glazebrook C. Physical activity interventions in children and young people with type 1 diabetes mellitus: a systemic review with meta-analysis. Diabet Med J Br Diabet Assoc 2014;31:1163-1173.
  4. Chimen M, Kennedy A, Nirantharakumar K, Pang TT, Andrews R & Narendran P. What are the health benefits of physical activity n type 1 diabetes mellitus? A literature review. Diabetologia 2012;55:542-551.
  5. Brazeau AS, Rabasa-Lhoret R, Strychar I & Mircescu H. Barriers physical activity among patients with type 1 diabetes. Diabetes Care 2008;31:2108-2109.
  6. Lascar N, Kenned A, Hancock et al. Attitudes and barriers to exercise in adults with type 1 diabetes and how best to address them: a qualitative study. PLoS One 2014;9:e108019.
  7. Riddell M, Gallen I, Smart C et al. Exercise management in type 1 diabetes: a consensus statement. Lancet Diabetes Endocrinolo 2017;5:377-390.
  8. Camacho RC, Galassetti P, Davis SN & Wasserman DH. Glucoregulation during and after exercise in health and insulin-dependent diabetes. 2005;33:17-21.
  9. Ploug T, Galbo H & Richter EA. Increased muscle glucose uptake during contractions: no need for insulin. Am J Physio 1984;247:E726-731.
  10. Coyle EF. Substrate utilisation during exercise in active people. Am J Clin Nutr 1995;61(suppl 4):968S-979S.
  11. Venables MC, Achten J & Jeukendrup AE. Determinants of fat oxidation during exercise in healthy men and women: a cross-sectional study. J Appl Physiol 2005;98:160-167.
  12. Van Loon LJ, Greenhaff PL, Constantin-Teodosiu D, Saris WH & Wagenmakers AJ. The effects of in-creasing exercise intensity on muscle fuel utilisation in humans. J Physiol 2001;536:295-304.
  13. Bally L, Laimer M & Stettler C. Exercise-associated glucose metabolism in individuals with type 1 di-abetes mellitus. Curr Opin Clin Nutr Metab Care 2015;18:428-433.
  14. Mallad A, Hinshaw L, Schivan M et al. Exercise effects on post-prandial glucose metabolism in type 1 diabetes: a triple tracer approach. Am J Physiol Endocrinol Metab 2015;308:E1106-1115.
  15. Garca-Carcia F, Kumareswaran K, Hovorka R & Hernando ME. Quantifying the acute changes in glu-cose with exercise in type 1 diabetes: a systematic review and meta-analysis. Sports Med 2015;45:587-599.
  16. Yardly JE, Kenny GP, Perkins BA et al. Effects of performing resistance exercise before versus after aerobic exercise on glycaemia in type 1 diabetes. Diabetes Care 2012;35:669-675.
  17. Guelfi KJ, Ratnam N, Smythe GA, Jones TW & Fournier PA. Effect of intermittent high-intensity compared with continuous moderate exercise on glucose production and utilisation in individuals with type 1 diabetes. Am J Physiol Endocrinol Metab 2007;292:E865-870.
  18. Teich T & Riddell MC. The enhancement of muscle insulin sensitivity after exercise: a Rac1-independent handoff to some other player? Endocrinology 2016;157:2999-3001.
  19. Gomez AM, Gomez C, Aschner P et al. Effects of performing morning versus afternoon exercise on glycaemic control and hypoglycaemia frequency in type 1 diabetes patients on sensor-augmented insulin pump therapy. J Diabetes Sci Technol 2015;9:619-624.


p24-27 Poverty and Diabetes:

  1. Australian Bureau of Statistics. Australian health survey: first results, 2011–12. Canberra: Australian Government; 2012.
  2. Stringhini S, Carmeli C, Jokela M, Avendaño M, Muennig P, Guida F, et al. Socioeconomic status and the 25 × 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1•7 million men and women. The Lancet. 2017;389(10075):1229-37.
  3. Australian Institute of Health and Welfare. Impact of overweight and obesity as a risk factor for chronic conditions: Australian Burden of Disease Study. . Canberra: AIHW; 2017. Contract No.: Australian Burden of Disease Study series no.11.
  4. Williams ED, Tapp RJ, Magliano DJ, Shaw JE, Zimmet PZ, Oldenburg BF. Health behaviours, socioeconomic status and diabetes incidence: the Australian Diabetes Obesity and Lifestyle Study (AusDiab). Diabetologia. 2010;53(12):2538-45.
  5. Stringhini S, Tabak AG, Akbaraly TN, Sabia S, Shipley MJ, Marmot MG, et al. Contribution of modifiable risk factors to social inequalities in type 2 diabetes: prospective Whitehall II cohort study. BMJ : British Medical Journal. 2012;345.
  6. Puolakka E, Pahkala K, Laitinen TT, Magnussen CG, Hutri-Kähönen N, Tossavainen P, et al. Childhood Socioeconomic Status in Predicting Metabolic Syndrome and Glucose Abnormalities in Adulthood: The Cardiovascular Risk in Young Finns Study. Diabetes Care. 2016;39(12):2311-7.
  7. Fismen A-S, Smith ORF, Torsheim T, Rasmussen M, Pagh TP, Augustine L, et al. Trends in food habits and their relation to socioeconomic status among Nordic adolescents 2001/2002-2009/2010. PloS one. 2016;11(2):e0148541.
  8. Kivimäki M, Virtanen M, Kawachi I, Nyberg ST, Alfredsson L, Batty GD, et al. Long working hours, socioeconomic status, and the risk of incident type 2 diabetes: a meta-analysis of published and unpublished data from 222 120 individuals. The Lancet Diabetes & Endocrinology. 2015;3(1):27-34.
  9. Astell-Burt T, Feng X, Kolt GS. Is Neighborhood Green Space Associated With a Lower Risk of Type 2 Diabetes? Evidence From 267,072 Australians. Diabetes Care. 2014;37(1):197-201.
  10. Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. The Lancet. 2006;368(9548):1673-9.
  11. Thomas C, Sadler S, Breeze P, Squires H, Gillett M, Brennan A. Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation. BMJ open. 2017;7(8):e014953.
  12. Eakin E, Reeves M, Lawler S, Graves N, Oldenburg B, Del Mar C, et al. Telephone Counseling for Physical Activity and Diet in Primary Care Patients. American Journal of Preventive Medicine. 2009;36(2):142-9.
  13. Community Preventive Services Task Force. Diabetes Prevention: Interventions Engaging Community Health Workers: Finding and Rationale Statement. Atlanta: US Centers for Disease Control and Prevention (CDC); 2016.
  14. McDermott RA, Schmidt B, Preece C, Owens V, Taylor S, Li M, et al. Community health workers improve diabetes care in remote Australian Indigenous communities: results of a pragmatic cluster randomized controlled trial. BMC Health Serv Res. 2015;15:68.
  15. Grintsova O, Maier W, Mielck A. Inequalities in health care among patients with type 2 diabetes by individual socio-economic status (SES) and regional deprivation: a systematic literature review. International Journal for Equity in Health. 2014;13(1):43.
  16. 16. S. FE, A. FC, B. D, H. B, E. E, A. G, et al. Impact of socio‐economic position on health and quality of care in adults with Type 2 diabetes in France: the Entred 2007 study. Diabetic Medicine. 2015;32(11):1438-44.
  17. Nam S, Chesla C, Stotts NA, Kroon L, Janson SL. Barriers to diabetes management: Patient and provider factors. Diabetes Research and Clinical Practice. 2011;93(1):1-9.
  18. von Wagner C, Steptoe A, Wolf MS, Wardle J. . Health Literacy and Health Actions: A Review and a Framework From Health Psychology. Health Education and Behaviour. 2009;36:860-77.
  19. Schillinger D, Bindman A, Want F, Stewart A, Piette J. Functional health literacy and the quality of physician-patient communication among diabetes patients. Patient Educ Couns. 2004;52:315-23.
  20. Beach M, Roter D, Wang N, Duggan P, Cooper L. . Are physicians’ attitudes of respect accurately perceived by patients and associated with more positive communication behaviours? . Patient Education and Counselling. 2006;62:347-54.
  21. Weiss BD. Health literacy and patient safety: help patients understand. Manual for clinicians: American Medical Association Foundation; 2007.
  22. Tran DT, Jorm LR, Havard A, Harris MF, Comino EJ. Variation in the use of primary care services for diabetes management according to country of birth and geography among older Australians. Primary Care Diabetes. 2016;10(1):66-74.
  23. Hacker K, Choi YS, Trebino L, Hicks L, Friedman E, Blanchfield B, et al. Exploring the impact of language services on utilization and clinical outcomes for diabetics. PloS one. 2012;7(6):e38507.
  24. Peek ME, Cargill A, Huang ES. Diabetes Health Disparities: A Systematic Review of Health Care Interventions. Medical care research and review : MCRR. 2007;64(5 Suppl):101S-56S.
  25. Whitehead L, Seaton P. The Effectiveness of Self-Management Mobile Phone and Tablet Apps in Long-term Condition Management: A Systematic Review. Journal of Medical Internet Research. 2016;18(5):e97.
  26. Wayne N, Perez DF, Kaplan DM, Ritvo P. Health Coaching Reduces HbA1c in Type 2 Diabetic Patients From a Lower-Socioeconomic Status Community: A Randomized Controlled Trial. Journal of Medical Internet Research. 2015;17(10):e224.
  27. Dou K, Yu P, Deng N, Liu F, Guan Y, Li Z, et al. Patients’ Acceptance of Smartphone Health Technology for Chronic Disease Management: A Theoretical Model and Empirical Test. JMIR mHealth and uHealth. 2017;5(12):e177.
  28. Walker RJ, Smalls BL, Campbell JA, Strom Williams JL, Egede LE. Impact of social determinants of health on outcomes for type 2 diabetes: a systematic review. Endocrine. 2014;47(1):29-48.
  29. Hart JT. The inverse care law. The Lancet. 1971;297(7696):405-12.


p28-29 Reality Check – Dealing with Chaotic Lives

  1. Klostermann BK, Slap GB, Nebrig DM, Tivorsak TL, Britto MT. Earning trust and losing it: Ado-lescents’ views on trusting physicians. J Fam Pract 2005;54(8):679–87. Search PubMed
  2. Hanghøj S, Boisen KA. Self-reported barriers to medication adherence among chronically ill ad-olescents: A systematic review. J Adolesc Health 2014;54(2):121–38. Search PubMed
  3. Britto MT, DeVellis RF, Hornung RW, DeFriese GH, Atherton HD, Slap GB. Health care prefer-ences and priorities of adolescents with chronic illnesses. Pediatrics 2004;114(5):1272–80. Search PubMed
  4. Beresford BA, Sloper P. Chronically ill adolescents’ experiences of communicating with doctors: A qualitative study. J Adolesc Health 2003;33(3):172–79. Search PubMed
  5. National Collaborating Centre for Women's and Children's Health. Diabetes in Pregnancy: manage-ment of diabetes and its complications from preconception to the postnatal period. NICE 2015 Accessed June 2015.
  6. Hojat M Louis DZ, Markham FW et al Physicians’ empathy and clinical outcomes for diabetic patients. Acad Med 86:359-364 2011
  7. Caroline Webb. How to have a good Day, 2016, Crown Business
  8. Lieberman M, (2013) Social: Why our brains are wired to Connect New York, Crown Archetype


p30-31 Patient Point of View – Fear of Hypoglycaemia

  1. NDSS. Mastering Diabetes booklet:
    Ebook: http://ebooks.edocumentonline.com/BUCKNER/mastering_diabetes_june_2016/
    PDF: https://static.diabetesaustralia.com.au/s/fileassets/diabetes-australia/f3133e0a-eb9a-45bf-900f-d98710a9ce0a.pdf


p32-34 Food Stuff: What’s the deal with artificial sweeteners?

  1. Arnold DL, Krewski D, Munro IC. Saccharin: a toxicological and historical perspective. Toxicology. 1983 Jul-Aug;27(3-4):179-256. https://www.ncbi.nlm.nih.gov/pubmed/6353664
  2. Food Standards Australia New Zealand http://www.foodstandards.gov.au/consumer/additives/intensesweetener/Pages/default.aspx
  3. World Health Organization Guideline: Sugars Intake for adults and children 2015 http://apps.who.int/iris/bitstream/handle/10665/149782/9789241549028_eng.pdf;jsessionid=AD5CFA9252560E23883E609C29312FFF?sequence=1
  4. Australian Bureau of Statistics 4364.0.55.011 - Australian Health Survey: Consumption of added sugars, 2011-12 http://www.abs.gov.au/ausstats/abs@.nsf/mf/4364.0.55.011
  5. http://www.glycemicindex.com/foodSearch.php
  6. Samarghandian S, Farkhondeh T, and Samini F. Honey and Health: A Review of Recent Clinical Research Pharmacognosy Res. 2017 Apr-Jun; 9(2): 121–127. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424551
  7. Barclay A, Sandall P, Shwide-Slavin C. The Ultimate Guide to Sugars and Sweeteners. 2014. The Experiment New York ISBN 978-1-61519-216-8
  8. The University of Sydney Glycemic Index testing service www.glycemicindex.com
  9. https://www.csrsugar.com.au/csr-sugar/our-products/better-you/logicane-low-gi-sugar/
  10. Pubchem Open Chemistry database - Glycerin https://pubchem.ncbi.nlm.nih.gov/compound/753
  11. https://en.wikipedia.org/wiki/Glycerol#Food_industry
  12. Bellisle F and Drewnowski A. Intense sweeteners, energy intake and the control of body weight European Journal of Clini-cal Nutrition 2007;61:691–700 https://www.nature.com/articles/1602649.pdf
  13. Suez J, Korem T, Zeevi D et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature. 2014 Oct 9;514(7521):181-6. doi: 10.1038/nature13793. https://www.ncbi.nlm.nih.gov/pubmed/25231862
  14. Australian Bureau of Statistics 4364.0.55.007 - Australian Health Survey: Nutrition First Results - Foods and Nutrients, 2011-12 – Sugar products and dishes http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/by%20Subject/4364.0.55.007~2011-12~Main%20Features~Sugar%20products%20and%20dishes~726
  15. Australian Bureau of Statistics 4364.0.55.007 - Australian Health Survey: Nutrition First Results - Foods and Nutrients, 2011-12 Table 18 http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/4364.0.55.0072011-12?OpenDocument
  16. http://www.foodstandards.gov.au/consumer/additives/intensesweetener/Pages/default.aspx
  17. Australia New Zealand Food Standards Code Schedule 15 Substances that may be used as food additives https://www.legislation.gov.au/Details/F2017C00331
  18. https://www.mordorintelligence.com/industry-reports/artificial-sweeteners-market
  19. https://globenewswire.com/news-release/2018/01/16/1289637/0/en/Artificial-Sweeteners-Market-Expected-to-Grow-at-a-CAGR-of-4-7-During-2017-2026-globally-Future-Market-Insights.html
  20. https://www.hyetsweet.com/cost-saving-sweeteners
  21. https://www.convenienceworldmagazine.com.au/half-of-australians-believe-artificial-sweeteners-are-unhealthy/
  22. Lohner S, IJoerg J. Meerpohl JJ. Health outcomes of non-nutritive sweeteners: analysis of the research landscape. Nutr J. 2017; 16: 55. doi: 10.1186/s12937-017-0278-x https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591507/
  23. Imamura F, O'Connor L, Ye Z, et al. Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attribut-able fraction. BMJ. 2015 Jul 21;351:h3576. doi: 10.1136/bmj.h3576. https://www.ncbi.nlm.nih.gov/pubmed/26199070
  24. Fagherazzi G, Gusto G, Affret A, et al. Chronic Consumption of Artificial Sweetener in Packets or Tablets and Type 2 Dia-betes Risk: Evidence from the E3N-European Prospective Investigation into Cancer and Nutrition Study. Ann Nutr Metab. 2017;70(1):51-58. doi: 10.1159/000458769. https://www.ncbi.nlm.nih.gov/pubmed/28214853
  25. Sakurai M, Nakamura K, Miura K, et al. Sugar-sweetened beverage and diet soda consumption and the 7-year risk for type 2 diabetes mellitus in middle-aged Japanese men. Eur J Nutr. 2014 Feb;53(1):251-8. doi: 10.1007/s00394-013-0523-9. https://www.ncbi.nlm.nih.gov/pubmed/23575771
  26. O’Connor L, Imamura F, Lenties M et al. Prospective associations and population impact of sweet beverage intake and type 2 diabetes, and effects of substitutions with alternative beverages. Diabetologia. 2015; 58(7): 1474–1483. doi: 10.1007/s00125-015-3572-1 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473082/
  27. Huang M, Quddus A, Stinson L et al. Artificially sweetened beverages, sugar-sweetened beverages, plain water, and inci-dent diabetes mellitus in postmenopausal women: the prospective Women's Health Initiative observational study. Am J Clin Nutr. 2017 Aug;106(2):614-622. doi: 10.3945/ajcn.116.145391. https://www.ncbi.nlm.nih.gov/pubmed/28659294
  28. Sylvetsky Meni AC, Swithers SE, and Rother KI et al. Positive association between artificially sweetened beverage con-sumption and incidence of diabetes. Diabetologia. 2015 Oct; 58(10): 2455–2456. doi: 10.1007/s00125-015-3694-5 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575240/#R1
  29. Suez J, Korem T, Zeevi D, et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 2014 Oct 9;514(7521):181-6. doi: 10.1038/nature13793. https://www.nature.com/articles/nature13793
  30. Ruanpeng D, Thongprayoon C, Cheungpasitporn W, Harindhanavudhi T. Sugar and artificially sweetened beverages linked to obesity: a systematic review and meta-analysis. QJM. 2017 Aug 1;110(8):513-520. doi: 10.1093/qjmed/hcx068. https://www.ncbi.nlm.nih.gov/pubmed/28402535
  31. Rogers PJ, Hogenkamp PS, de Graaf C et al. Does low-energy sweetener consumption affect energy intake and body weight? A systematic review, including meta-analyses, of the evidence from human and animal studies. Int J Obes (Lond) 2016 Mar; 40(3): 381–394. doi: 10.1038/ijo.2015.177 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786736
  32. Miller PE, Perez V. Low-calorie sweeteners and body weight and composition: a meta-analysis of randomized controlled trials and prospective cohort studies. Am J Clin Nutr. 2014 Sep;100(3):765-77. doi: 10.3945/ajcn.113.082826. https://www.ncbi.nlm.nih.gov/pubmed/24944060
  33. Mandrioli D, Kearns CE, and Bero LA. Relationship between Research Outcomes and Risk of Bias, Study Sponsorship, and Author Financial Conflicts of Interest in Reviews of the Effects of Artificially Sweetened Beverages on Weight Out-comes: A Systematic Review of Reviews PLoS One. 2016; 11(9): e0162198 doi: 10.1371/journal.pone.0162198 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015869/
  34. Romo-Romo A, Aguilar-Salinas CA, Brito-Córdova GX, et al. Effects of the Non-Nutritive Sweeteners on Glucose Metabo-lism and Appetite Regulating Hormones: Systematic Review of Observational Prospective Studies and Clinical Trials. PLoS One. 2016; 11(8): e0161264. doi: 10.1371/journal.pone.0161264 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990242
  35. Cheungpasitporn W, Thongprayoon C, Edmonds PJ et al. Sugar and artificially sweetened soda consumption linked to hy-pertension: a systematic review and meta-analysis. Clin Exp Hypertens. 2015;37(7):587-93. doi: 10.3109/10641963.2015.1026044. https://www.ncbi.nlm.nih.gov/pubmed/26114357
  36. Lin J, Curhan GC. Associations of sugar and artificially sweetened soda with albuminuria and kidney function decline in women. Clin J Am Soc Nephrol. 2011 Jan;6(1):160-6. doi: 10.2215/CJN.03260410. https://www.ncbi.nlm.nih.gov/pubmed/20884773
  37. Cheungpasitporn W, Thongprayoon C, O'Corragain OA et al. Associations of sugar-sweetened and artificially sweetened soda with chronic kidney disease: a systematic review and meta-analysis. Nephrology (Carlton). 2014 Dec;19(12):791-7. doi: 10.1111/nep.12343. https://www.ncbi.nlm.nih.gov/pubmed/25251417
  38. Rebholz CM, Grams ME, Steffen LM, et al. Diet Soda Consumption and Risk of Incident End Stage Renal Disease. Clin J Am Soc Nephrol. 2017 Jan 6;12(1):79-86. doi: 10.2215/CJN.03390316. https://www.ncbi.nlm.nih.gov/pubmed/27797893
  39. Narain A, Kwok CS, Mamas MA. Soft drinks and sweetened beverages and the risk of cardiovascular disease and mortality: a systematic review and meta-analysis. Int J Clin Pract. 2016 Oct;70(10):791-805. doi: 10.1111/ijcp.12841. https://www.ncbi.nlm.nih.gov/pubmed/27456347
  40. Chen L, Hu FB, Yeung E et al. Prospective study of pre-gravid sugar-sweetened beverage consumption and the risk of ges-tational diabetes mellitus. Diabetes Care. 2009 Dec;32(12):2236-41. doi: 10.2337/dc09-0866. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782983/
  41. Azad MB, Sharma AK, de Souza RJ et al. Canadian Healthy Infant Longitudinal Development Study Investigators. Associa-tion Between Artificially Sweetened Beverage Consumption During Pregnancy and Infant Body Mass Index. JAMA Pe-diatr. 2016 Jul 1;170(7):662-70. doi: 10.1001/jamapediatrics.2016.0301. https://www.ncbi.nlm.nih.gov/pubmed/27159792
  42. Zhu Y, Olsen SF, Mendola P, et al. Maternal consumption of artificially sweetened beverages during pregnancy, and off-spring growth through 7 years of age: a prospective cohort study. Int J Epidemiol. 2017 Oct 1;46(5):1499-1508. doi: 10.1093/ije/dyx095. https://www.ncbi.nlm.nih.gov/pubmed/28586472
  43. Maslova E, Strøm M, Olsen SF, Halldorsson TI. Consumption of artificially-sweetened soft drinks in pregnancy and risk of child asthma and allergic rhinitis. PLoS One. 2013;8(2):e57261. doi: 10.1371/journal.pone.0057261. https://www.ncbi.nlm.nih.gov/pubmed/23460835


-- ENDS --